Navigation Links
C8 Lawsuit Filed By Wright & Schulte LLC on Behalf of Ohio Woman Stricken with Thyroid Cancer Allegedly Due to C8 Tainted Drinking Water
Date:8/18/2013

Columbus, OH (PRWEB) August 19, 2013

The C8 lawsuit lawyers at Wright & Schulte LLC announce that they have filed a C8 lawsuit on behalf of an Ohio woman who developed thyroid disease and thyroid cancer, allegedly due to exposure to drinking water contaminated with C8, a toxic chemical discharged from DuPont’s Washington Works Plant in Parkersburg, West Virginia. The C8 lawsuit, which was filed on August 8, 2013, in U.S. District Court, Southern District of Ohio, further alleges that the Plaintiff was caused to sustain severe and permanent personal injuries, pain, suffering, and emotional distress due to DuPont’s negligence. (2:13-cv-00792- JLG-TPK)

Wright & Schulte LLC continues to offer free C8 lawsuit consultations to anyone who may have been exposed to C8 tainted drinking water associated with the DuPont facility. Individuals who lived or worked in certain Ohio and West Virginia water districts prior to December 3, 2004, or their survivors, may be entitled to file a C8 lawsuit for personal injury or wrongful death if they or their loved one suffered from an illness that may be linked to C8 exposure, including:

  •     Kidney cancer
  •     Testicular cancer
  •     Thyroid disease
  •     Inflammatory bowel disease (ulcerative colitis)
  •     Preeclampsia (high blood pressure during pregnancy)
  •     High cholesterol

For more information on filing a C8 lawsuit, or to arrange for a free legal consultation with an attorney from Wright & Schulte LLC, please visit yourlegalhelp.com. Follow Wright & Schulte's C8 Facebook page for all current news and information regarding C8 water contamination and C8 lawsuits.

C8 is a chemical used in the manufacture of Teflon, and was discharged from the Washington Works plant for decades. This latest C8 lawsuit filed by Wright & Schulte LLC is one of dozens of similar complaints pending in a multidistrict litigation established in the Southern District of Ohio for claims filed in accordance with the 2005 C8 class action lawsuit settlement. That accord, which DuPont reached with 70,000 people who lived and worked in the vicinity of the Washington Works facility, held that anyone who had been exposed to C8 contaminated water would be eligible to file a personal injury lawsuit if they developed a disease ultimately determined to be associated with C8 exposure. To qualify to file an individual C8 lawsuit, potential plaintiffs must have been diagnosed with a related diseased, and they must have lived in one of six water districts stipulated by the settlement prior to December 3, 2004. Those six water districts are:

  •     Little Hocking, Ohio
  •     Belpre, Ohio
  •     Village of Pomeroy, Ohio
  •     Tuppers Plains, Ohio
  •     Lubeck Public Service District, West Virginia
  •     Mason County Public Service District, West Virginia
(Leach v. E.I. Du Pont De Nemours & Co., No. 01-C-608 (W. Va. Cir. Ct.))

In October 2012, the C8 Science Panel announced it had found probable links between the chemical and a number of disorders, including testicular and kidney cancers, pregnancy-induced hypertension (pre-eclampsia), thyroid disease, high cholesterol and inflammatory bowel disease.
(c8sciencepanel.org/)

According to court documents, the U.S. Judicial Panel on Multidistrict Litigation issued an order in April 2013 that transferred all federal C8 lawsuits alleging personal injury or wrongful death to the Southern District of Ohio for consolidated pretrial proceedings. Wright & Schulte LLC partner, Richard W. Schulte, has been appointed to the Plaintiffs’ Steering Committee in the federal litigation. All of the C8 lawsuits pending in the multidistrict litigation allege that DuPont had information in its possession as early as the 1980s that indicated exposure to C8-tainted drinking water could lead to various adverse health consequences in exposed workers. Plaintiffs further allege that DuPont has known for several decades that discharge of C8 into the Ohio River from the Washington Works contaminated water supplies, and that C8 pollution from the facility could be reduced substantially by use of a carbon absorption treatment system. (In Re: E.I. DuPont De Nemours and Company C-8 Personal Injury Litigation, MDL No. 2433)

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free DuPont C8 lawsuit case evaluations are available through yourlegalhelp.com, or call 1-888-399-0795.

Contact:
Wright Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com

Read the full story at http://www.prweb.com/releases/2013/8/prweb11038094.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
2. The Law Office of Wolf & Pravato, The Alters Firm and Morelli Ratner File Class Action Lawsuit Against Global Spray Foam Manufacturer
3. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
4. New Lawsuit Alleges Teen Molestation by Ex-Deputy
5. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
6. New Lawsuit on Propecia: Severe Adverse Events
7. New Lawsuit on Accutane Crohn’s Disease: Severe Adverse Events
8. New Lawsuit alleges Actos caused Bladder Cancer
9. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
10. Wright & Schulte File Skechers Lawsuit on Behalf of Ohio Woman Who Fell, Suffered Broken Wrist Allegedly Due to Use of Skechers Shape-Ups
11. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... Coast Dental Fort Stewart ... at its new location in the Exchange Furniture Mall at 112 Vilseck Road in ... 50-inch Samsung Smart TV. Plus attendees will have the opportunity to meet general dentists ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Wharton ... $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan Competition —as ... People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ making them ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Gluten-Free Certification Program ... to announce the launch of the GFCP Scoop in response to ... purpose of the GFCP Scoop site is to keep the gluten-free ...
(Date:4/29/2016)... ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon Dr. ... very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to offer this ... procedure that involves one or both jaw bones. This surgery is performed to correct the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the ... of funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... base and accelerate its technology and product roadmap. , “Jvion is ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
(Date:4/27/2016)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... second quarter ended March 26, 2016.  GAAP diluted ... and non-GAAP diluted EPS of $0.47 increased 14.6%.  ... reported basis, and 6.3% on a constant currency ... quarter, highlighted by 14.6% growth in non-GAAP EPS," ...
(Date:4/27/2016)... York , April 27, 2016 ... report titled, "Skincare Devices Market - Global Industry Analysis, ... According to the report, the global skincare devices market ... is anticipated to expand at a CAGR of 10.1% ... in 2023. Browse the full Skincare Devices Market ...
Breaking Medicine Technology: